The FINANCIAL — Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announces the launch of the generic equivalent to Exforge (amlodipine and valsartan) Tablets in four different strengths, in the United States.
Exforge (amlodipine and valsartan) Tablets are used in the treatment of high blood pressure (hypertension), a chronic condition often without symptoms that is linked to serious health issues such as heart disease and stroke, if not detected early and treated appropriately. With the launch of Amlodipine and Valsartan Tablets, Teva can offer those prescribed Exforge a generic alternative to help manage their high blood pressure.
Exforge (amlodipine and valsartan) Tablets had annual sales of approximately $409 million in the United States, according to IMS data as of January 2015, according to Teva.
Discussion about this post